New PET data show decreased dopamine D1 receptor binding in the prefrontal cortex of patients with schizophrenia.
1
The dopamine hypothesis proposes that schizophrenic
The first in vivo measurements of D1R in schizophrenia using PET and [ 11 C] SCH23390 were performed symptoms are caused by a functional hyperactivity of the mesolimbic dopaminergic system. Among the five dopaby Karlsson et al. 11 They found no changes in the measurements of D1R of the whole putamen. Submine receptor subtypes (D1-5) so far identified, a central role of D2R has been strongly indicated for symptoms of sequently, they measured D1R in the patch component of the putamen using the values of the four pixels with schizophrenia by the evidence that antipsychotic drugs block dopamine D2R in direct relation to their clinical the highest radioactivity, and found it lower in drugnaive schizophrenics. 12 They hypothesized that a low antipsychotic potencies.
2 Postmortem studies have also revealed the increased density of striatal D2R in schizo-D1R density may result in a reduced activity of D1R to D2R regulated feedback system to limbic regions in phrenics.
3 However, most recent PET studies reported the absence of notable changes in D2R in the striatum schizophrenia.
Recently, we reported a PET study of D1R and of schizophrenics. The role of the D1R system in the pathophysiology D2R in schizophrenia using [ 2 Furthermore, a recent clinical study of the selective D1 antagpreferentially labels D1R in the cortex in vivo. We observed that the D1R binding decreased in the onist SCH39166 failed to demonstrate an antipsychotic effect in schizophrenia.
6 It has been demonstrated that prefrontal cortex (PFC) of schizophrenics (see Image section) and that this reduction was related to negative chronic treatment with different antipsychotic drugs, clozapine, haloperidol and remoxipride, down-regusymptoms and poor performance in the Wisconsin Card Sorting Test, which assesses the neuropsychologlate D1R in prefrontal and temporal cortices in monkeys, 7 thus raising the possibility that down-regulation ical deficit most widely recognised as being associated with prefrontal function in humans. of D1R in these cortical areas may be an important component of the therapeutic response to antipsy-
The PFC of schizophrenic patients may be hypodopaminergic, and this decreased mesocortical dopaminergic chotic drugs.
There have been only a few postmortem studies on activity may induce poor performance in frontally mediated cognitive tasks and negative symptoms. 14 It is D1R in schizophrenia. Hess et al 8 reported elevated D2R density but reduced D1R density in the striatum proposed that a defect in working memory, the ability to guide behavior by representations, may be a fundamental of postmortem brains of schizophrenic patients, suggesting an imbalance of striatal D1R/D2R in schizocognitive disturbance in schizophrenia. 15 Furthermore, animal studies have indicated an important role of prephrenia. But others reported no changes in striatal D1R.
9 Recently, Knable et al 10 performed a postmortem frontal D1R in working memory. 16 Our findings suggest that the dysfunction in the D1R modulation mechanism study of prefrontal D1R and reported that neuroleptictreated controls displayed a significant elevation in in PFC may contribute to negative symptoms such as alogia, affective blunting, avolition, anhedonia clearly related to cognition, motivation, emotion and cognitive deficits in schizophrenia. be helpful in treating the negative symptoms of schizo-
